Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
31962 | 145 | 41.2 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
204 | 3 | PROTEASOME//UBIQUITIN//UNFOLDED PROTEIN RESPONSE | 52492 |
1195 | 2 | JNK//ERK5//MAP KINASE | 9252 |
31962 | 1 | PEA 15//IST ENDOCRINOL ONCOL SPERIMENTALE GAETANO SALVA//BIKDD | 145 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PEA 15 | authKW | 3110232 | 17% | 62% | 24 |
2 | IST ENDOCRINOL ONCOL SPERIMENTALE GAETANO SALVA | address | 689198 | 4% | 55% | 6 |
3 | BIKDD | authKW | 561570 | 3% | 67% | 4 |
4 | SPECT OURCE | address | 421180 | 1% | 100% | 2 |
5 | DEATH EFFECTOR DOMAIN | authKW | 291577 | 4% | 23% | 6 |
6 | PEA 15 PED | authKW | 280785 | 1% | 67% | 2 |
7 | U752 | address | 270755 | 2% | 43% | 3 |
8 | PED PEA 15 | authKW | 236910 | 2% | 38% | 3 |
9 | 67 LAMININ RECEPTOR | authKW | 210590 | 1% | 100% | 1 |
10 | ALCOHOL RESPONSE ELEMENT | authKW | 210590 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 558 | 32% | 0% | 47 |
2 | Oncology | 491 | 31% | 0% | 45 |
3 | Biochemistry & Molecular Biology | 406 | 45% | 0% | 65 |
4 | Genetics & Heredity | 93 | 12% | 0% | 17 |
5 | Endocrinology & Metabolism | 40 | 8% | 0% | 11 |
6 | Medicine, Research & Experimental | 35 | 7% | 0% | 10 |
7 | Biotechnology & Applied Microbiology | 18 | 6% | 0% | 9 |
8 | Developmental Biology | 10 | 2% | 0% | 3 |
9 | Biophysics | 10 | 4% | 0% | 6 |
10 | Neurosciences | 7 | 7% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IST ENDOCRINOL ONCOL SPERIMENTALE GAETANO SALVA | 689198 | 4% | 55% | 6 |
2 | SPECT OURCE | 421180 | 1% | 100% | 2 |
3 | U752 | 270755 | 2% | 43% | 3 |
4 | BASIC CLIN IMMUNOL SCI CISI | 210590 | 1% | 100% | 1 |
5 | BREAST MED ONCOL BIOINFORMAT COMPUTAT BI | 210590 | 1% | 100% | 1 |
6 | CHAIRE NEUROPHARMACOL NEUROPHARMACOL | 210590 | 1% | 100% | 1 |
7 | ENDOCRINOL EXPT ONCOL G SALVATORE IEOS | 210590 | 1% | 100% | 1 |
8 | INSERM U114 CHAIRE NEUROPHARMACOL | 210590 | 1% | 100% | 1 |
9 | INTEGRINS CANC PHARMLBP | 210590 | 1% | 100% | 1 |
10 | IST BIOSTRUTTURE BIOIMMAGINI IBB | 210590 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR CANCER THERAPEUTICS | 1858 | 4% | 0% | 6 |
2 | ONCOGENE | 936 | 6% | 0% | 9 |
3 | ONCOGENESIS | 799 | 1% | 0% | 1 |
4 | MOLECULAR THERAPY-NUCLEIC ACIDS | 695 | 1% | 0% | 1 |
5 | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 687 | 2% | 0% | 3 |
6 | MOLECULAR BIOLOGY OF THE CELL | 626 | 3% | 0% | 5 |
7 | CANCER CELL | 548 | 1% | 0% | 2 |
8 | CHEMICAL BIOLOGY & DRUG DESIGN | 507 | 1% | 0% | 2 |
9 | BRAIN AND BEHAVIOR | 423 | 1% | 0% | 1 |
10 | JOURNAL OF BIOLOGICAL CHEMISTRY | 339 | 11% | 0% | 16 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PEA 15 | 3110232 | 17% | 62% | 24 | Search PEA+15 | Search PEA+15 |
2 | BIKDD | 561570 | 3% | 67% | 4 | Search BIKDD | Search BIKDD |
3 | DEATH EFFECTOR DOMAIN | 291577 | 4% | 23% | 6 | Search DEATH+EFFECTOR+DOMAIN | Search DEATH+EFFECTOR+DOMAIN |
4 | PEA 15 PED | 280785 | 1% | 67% | 2 | Search PEA+15+PED | Search PEA+15+PED |
5 | PED PEA 15 | 236910 | 2% | 38% | 3 | Search PED+PEA+15 | Search PED+PEA+15 |
6 | 67 LAMININ RECEPTOR | 210590 | 1% | 100% | 1 | Search 67+LAMININ+RECEPTOR | Search 67+LAMININ+RECEPTOR |
7 | ALCOHOL RESPONSE ELEMENT | 210590 | 1% | 100% | 1 | Search ALCOHOL+RESPONSE+ELEMENT | Search ALCOHOL+RESPONSE+ELEMENT |
8 | CASDIAC | 210590 | 1% | 100% | 1 | Search CASDIAC | Search CASDIAC |
9 | ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 4 ENTPD4 | 210590 | 1% | 100% | 1 | Search ECTONUCLEOSIDE+TRIPHOSPHATE+DIPHOSPHOHYDROLASE+4+ENTPD4 | Search ECTONUCLEOSIDE+TRIPHOSPHATE+DIPHOSPHOHYDROLASE+4+ENTPD4 |
10 | EGFR DEPHOSPHORYLATION | 210590 | 1% | 100% | 1 | Search EGFR+DEPHOSPHORYLATION | Search EGFR+DEPHOSPHORYLATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GREIG, FH , NIXON, GF , (2014) PHOSPHOPROTEIN ENRICHED IN ASTROCYTES (PEA)-15: A POTENTIAL THERAPEUTIC TARGET IN MULTIPLE DISEASE STATES.PHARMACOLOGY & THERAPEUTICS. VOL. 143. ISSUE 3. P. 265 -274 | 61 | 50% | 2 |
2 | FIORY, F , FORMISANO, P , PERRUOLO, G , BEGUINOT, F , (2009) FRONTIERS: PED/PEA-15, A MULTIFUNCTIONAL PROTEIN CONTROLLING CELL SURVIVAL AND GLUCOSE METABOLISM.AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. VOL. 297. ISSUE 3. P. E592-E601 | 40 | 58% | 29 |
3 | FUNKE, V , LEHMANN-KOCH, J , BICKEBOLLER, M , BENNER, A , TAGSCHERER, KE , GRUND, K , PFEIFER, M , HERPEL, E , SCHIRMACHER, P , CHANG-CLAUDE, J , ET AL (2013) THE PEA-15/PED PROTEIN REGULATES CELLULAR SURVIVAL AND INVASIVENESS IN COLORECTAL CARCINOMAS.CANCER LETTERS. VOL. 335. ISSUE 2. P. 431-440 | 32 | 67% | 5 |
4 | ECKERT, A , BOCK, BC , TAGSCHERER, KE , HAAS, TL , GRUND, K , SYKORA, J , HEROLD-MENDE, C , EHEMANN, V , HOLLSTEIN, M , CHNEIWEISS, H , ET AL (2008) THE PEA-15/PED PROTEIN PROTECTS GLIOBLASTOMA CELLS FROM GLUCOSE DEPRIVATION-INDUCED APOPTOSIS VIA THE ERK/MAP KINASE PATHWAY.ONCOGENE. VOL. 27. ISSUE 8. P. 1155 -1166 | 26 | 70% | 21 |
5 | KRUEGER, J , CHOU, FL , GLADING, A , SCHAEFER, E , GINSBERG, MH , (2005) PHOSPHORYLATION OF PHOSPHOPROTEIN ENRICHED IN ASTROCYTES (PEA-15) REGULATES EXTRACELLULAR SIGNAL-REGULATED KINASE-DEPENDENT TRANSCRIPTION AND CELL PROLIFERATION.MOLECULAR BIOLOGY OF THE CELL. VOL. 16. ISSUE 8. P. 3552-3561 | 25 | 64% | 47 |
6 | XIE, XH , TANG, HL , LIU, P , KONG, YA , WU, MQ , XIAO, XS , YANG, L , GAO, J , WEI, WD , LEE, J , ET AL (2015) DEVELOPMENT OF PEA-15 USING A POTENT NON-VIRAL VECTOR FOR THERAPEUTIC APPLICATION IN BREAST CANCER.CANCER LETTERS. VOL. 356. ISSUE 2. P. 374 -381 | 20 | 65% | 2 |
7 | RENGANATHAN, H , VAIDYANATHAN, H , KNAPINSKA, A , RAMOS, JW , (2005) PHOSPHORYLATION OF PEA-15 SWITCHES ITS BINDING SPECIFICITY FROM ERK/MAPK TO FADD.BIOCHEMICAL JOURNAL. VOL. 390. ISSUE . P. 729-735 | 16 | 89% | 68 |
8 | WATANABE, Y , YAMASAKI, F , KAJIWARA, Y , SAITO, T , NISHIMOTO, T , BARTHOLOMEUSZ, C , UENO, NT , SUGIYAMA, K , KURISU, K , (2010) EXPRESSION OF PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15 KDA (PEA-15) IN ASTROCYTIC TUMORS: A NOVEL APPROACH OF CORRELATING MALIGNANCY GRADE AND PROGNOSIS.JOURNAL OF NEURO-ONCOLOGY. VOL. 100. ISSUE 3. P. 449-457 | 18 | 69% | 7 |
9 | HALING, JR , WANG, F , GINSBERG, MH , (2010) PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15 KDA (PEA-15) REPROGRAMS GROWTH FACTOR SIGNALING BY INHIBITING THREONINE PHOSPHORYLATION OF FIBROBLAST RECEPTOR SUBSTRATE 2 ALPHA.MOLECULAR BIOLOGY OF THE CELL. VOL. 21. ISSUE 4. P. 664-673 | 25 | 50% | 4 |
10 | BARTHOLOMEUSZ, C , GONZALEZ-ANGULO, AM , KAZANSKY, A , KRISHNAMURTHY, S , LIU, P , YUAN, LDXH , YAMASAKI, F , LIU, SY , HAYASHI, N , ZHANG, DW , ET AL (2010) PEA-15 INHIBITS TUMORIGENESIS IN AN MDA-MB-468 TRIPLE-NEGATIVE BREAST CANCER XENOGRAFT MODEL THROUGH INCREASED CYTOPLASMIC LOCALIZATION OF ACTIVATED EXTRACELLULAR SIGNAL-REGULATED KINASE.CLINICAL CANCER RESEARCH. VOL. 16. ISSUE 6. P. 1802-1811 | 17 | 63% | 16 |
Classes with closest relation at Level 1 |